# Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)

> **NCT00249405** · PHASE2 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 200 (estimated)

## Conditions studied

- Alcoholism
- Alcohol Abuse

## Interventions

- **DRUG:** Citalopram + MI
- **BEHAVIORAL:** Placebo + MI

## Key facts

- **NCT ID:** NCT00249405
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2010-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249405, "Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00249405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*